内分泌与代谢:Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical Trial.
原文摘录:OBJECTIVE: Optimizing second-line therapy for type 2 diabetes remains challenging because of interindividual variability in response. Current treatment selection does not consider personal genetic profiles.
关注理由:这条内分泌与代谢内容涉及随机对照研究,除了结论,还应看看样本量、主要终点和不良事件报告。